Article info

Download PDFPDF

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
  1. Correspondence to:
    Dr J D Lewis
    University of Pennsylvania, 720 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104-6021, USA; jlewiscceb.med.upenn.edu
View Full Text

Citation

Kandiel A, Fraser AG, Korelitz BI, et al
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

Publication history

  • Accepted January 4, 2005
  • Revised December 22, 2004
  • First published July 11, 2005.
Online issue publication 
July 11, 2005
  • Competing interest: JDL has received research support and has served as a consultant for Wyeth and GlaxoSmithKline. BIK has received research funding from Centocor. AK, AGF, and CB report no potential conflicts of interest.

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.